Stockreport

Cellectar stock surges 15% premarket after FDA fast tracks treatment for rare childhood cancer [MarketWatch]

Cellectar Biosciences, Inc.  (CLRB) 
Last cellectar biosciences, inc. earnings: 11/12 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.cellectar.com
PDF Cellectar stock surges 15% premarket after FDA fast tracks treatment for rare childhood cancer Cellectar Biosciences Inc. CLRB, +11.42% said Monday it has received Ra [Read more]